Roche's experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. in lowering blood sugar, according to the results of a late stage study.
| From | Comment |
|---|---|
|
jayabee52 |
October 31, 2009 5:02 AM Decided to do some digging, and found the article without having to subscribel to WSJ & posted it. |
|
jayabee52 |
October 31, 2009 4:38 AM BUMMER! You have to get a subscription to the Wall Street Journal to see more than just the first few lines of the article! |